Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature

Volume: 18, Issue: 4, Pages: 399 - 405
Published: Apr 1, 2019
Abstract
To assess the efficacy and safety of Rituximab (RTX) in adult primary central nervous system vasculitis (PCNSV).We retrospectively assessed the effect of RTX in 6 patients with PCNSV. Five of the 6 were refractory to high dose glucocorticoids (GCs) and/or conventional immunosuppressants (IS). The sixth was newly diagnosed and received RTX in combination with GCs. Clinical evaluation, laboratory tests, and imaging modalities were performed at...
Paper Details
Title
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature
Published Date
Apr 1, 2019
Volume
18
Issue
4
Pages
399 - 405
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.